Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Dendreon | Contract Pharma

What are you searching for?

Sign in

Dendreon

brand-profile-thumb

Company Headquarters

1700 Saturn Way Seal Beach , CA 90740 US

Driving Directions
View website

Brand Description

Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreon

Key Personnel

NAME
JOB TITLE
  • Michael Pearson
    CEO / President
  • Greg Cox
    EVP - CFO/Treasurer
  • Stephen Apone
    Vice President, Manufacturing Sciences
  • Kevin Helmbacher
    SVP of Legal and Compliance and General Counsel
  • Chris Lockett
    Vice President, Immunotherapy Sales and Customer Relations
  • Nadeem Sheikh
    VP, Clinical Development, Medical Affairs
  • Lianng Yuh
    VP

Yearly results

*All sales figures and related information presented in this report are based on data from the previous calendar year.

Sales: $214000

Headcount: 1,475
Bio/Pharma Revenues: $214 (346%)
Total Revenues: $342 (613%)
Royalty Revenues: $128 (n/a)
Net Income: $338
R&D Budget: $74 (-3%)
Top-Selling Drugs

Drug Indication $ (+/- %)
Provenge prostate cancer $214 346%
Account for 100% of total biopharma sales, same as in 2010

Related Content